Pharmacists' perceptions and communication of risk for alertness impairing medications
Autor: | Ibrahim Jomaa, Keith Wong, Janet M Y Cheung, Bandana Saini, Jason Ellis, Tanya Smyth, Mariam Odisho |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
Risk Drug-Related Side Effects and Adverse Reactions Psychometrics Attitude of Health Personnel media_common.quotation_subject education Pharmacist Pharmaceutical Science B200 Community Pharmacy Services Pharmacy Pharmacists Interviews as Topic 03 medical and health sciences Professional Role 0302 clinical medicine Patient Education as Topic Nursing Surveys and Questionnaires Perception Humans Hypnotics and Sedatives Risk communication Medicine 030212 general & internal medicine media_common Psychomotor learning business.industry Communication Risk perception Alertness Workflow Psychotropic drug Female business 030217 neurology & neurosurgery |
Zdroj: | Research in Social and Administrative Pharmacy. 14:31-45 |
ISSN: | 1551-7411 |
DOI: | 10.1016/j.sapharm.2016.12.010 |
Popis: | Background - A core role of the pharmacist is to ensure safe and effective medication use. Therapeutic classes that impair alertness (e.g. sedatives or hypnotics) can pose safety concerns for the consumer when undertaking activities requiring psychomotor vigilance (e.g. driving).\ud \ud Objective - To explore pharmacists' perceptions and communication strategy of the risks related to alertness impairing medications in clinical practice.\ud \ud Methods - In-depth semi-structured interviews explored community pharmacists' perceptions of medication-related risks, current medication provision and the feasibility of new practice tools. Interviews were digitally recorded, transcribed verbatim and analysed using Framework Analysis to identify emergent themes. A Psychometric Risk Perception Questionnaire was also used to evaluate pharmacists' perceptions across 7 common psychotropic drug classes.\ud \ud Results - Synthesis of the qualitative dataset of 30 pharmacist interviews revealed three key themes: ‘Safety and Consequences of AIMs’, ‘Factors that Influence Risk Communication’ and ‘Refining Risk Communication’. Participating pharmacists were generally aware of the therapeutic classes associated with medication-related risks but were concerned about patients' level of understanding. Counselling approaches were largely dictated by perceived patient interest/experience with a medication. Concerns were centred on inter-individual pharmacokinetic differences, which could make the precise risk assignment difficult. Pharmacists also highlighted workflow limitations and the need to bring patients' attention to these resources during the clinical interaction to maximise impact.\ud \ud Conclusions - Medication-related risk communication is a complex clinical phenomenon dictated by patients' prior experiences and the pharmacists' practice environment. Extending the evidence base in this therapeutic area and refining clinical resources are key steps towards optimising patient medication safety. |
Databáze: | OpenAIRE |
Externí odkaz: |